AdaptResponse

Projekt

AdaptResponse

Abgeschlossen · 2016 bis 2022

Ammann Peter, Vetsch Susanne

Art

Klinische Forschung

Reichweite

Multizentrisch, KSSG als teilnehmendes Zentrum

Bereiche

Kardiologie

Status

Abgeschlossen

Start

2016

Ende

2022

Finanzierungsart

Industrie

Studiendesign

Following enrollment and baseline assessment, eligible subjects will be implanted with a CRT system containing the aCRT algorithm and randomized in a 1:1 fashion to either treatment (aCRT ON) or control (aCRT OFF) groups. Study subjects will be followed for a minimum of 24 months or until study closure, whichever comes first. Refer to the figure below for an overview of the study design

Kurzbeschreibung/Zielsetzung

The AdaptResponse study is a prospective, randomized, controlled, interventional, single-blinded, multi-center, post-market, global Cardiac Resynchronization Therapy (CRT) in heart failure (HF) clinical study.

The purpose of this clinical study is to test the hypothesis that market released CRT devices which contain the AdaptivCRT® (aCRT) algorithm have a superior outcome compared to standard CRT devices in CRT indicated patients with normal AV conduction and left bundle branch block (LBBB).